Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

89.93
Delayed Data
As of Aug 28
 +0.76 / +0.85%
Today’s Change
77.60
Today|||52-Week Range
134.26
-9.19%
Year-to-Date

Today’s Trading

Previous close89.17
Today’s open88.69
Day’s range87.80 - 90.20
Volume1,697,880
Average volume (3 months)1,622,137
Market cap$10.6B
Dividend yield--
Data as of 4:03pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+48.21%
Earnings growth (next 5 years)+15.81%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+2.05+1.20%
RDYDr.Reddy's Laborator...+0.05+0.08%
ALKSAlkermes Plc+1.98+3.24%
MDVNMedivation Inc+0.34+0.37%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$1.82
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers